Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE) (EMBODY 2)
Epratuzumab
SL0010
NCT01261793
Lupus
Phase 3
 
AD and ADaM are available for Analysis and Reporting Dataset

Datasets are available in English only
November 2015

Powered by ideaPoint, Inc.